Gives a complete deillegalscription on online hemodiafiltration
Provides a practical guide on how to perform the treatment
Each chapter is completed by a point-to-point summary of essential information
Menso J. Nubé is professor at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam, the Netherlands. He is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and an expert in cardiovascular disease in patients with kidney disease.
Muriel P.C. Grooteman is internist/nephrologist at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam. She is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and a specialist in cardiovascular complications of dialysis treatment.
Peter J. Blankestijn is internist/nephrologist and associate professor at the department of Nephrology at the University Medical Center Utrecht (UMCU) in Utrecht, the Netherlands. He is an expert in autonomic dysregulation in patients with end stage kidney disease, and involved in research on hemodialysis and hemodiafiltration since the 90s.
This book gives a complete deillegalscription of online hemodiafiltration, in five sections. It is unique in the systematic and complete way in which hemodiafiltration is described. Each chapter is completed by a point-to-point summary of essential information, in a separate text box. Part of the book is dedicated to the theoretical background of convective clearance. In this part, safety issues and quality control is reviewed (especially on the quality of water for dialysis and substitution fluid), as well as equipment (both dialyzers and machines) with which this treatment can be performed. As recently the results of several randomized controlled trials were available, the effect of hemodiafiltration on hard clinical end points (mortality and morbidity) is discussed in detail. This has not been done before, as the most recent book/journal on hemodiafiltration was published in 2011, before the results of the 3 randomized controlled trials were published. Furthermore, the methodological quality of the trials is discussed by an expert, in order to help the readers in their judgment of the trials Part of the book concentrates on the effect of the treatment on several biomarkers and uremic toxins. Several clinically relevant issues is discussed separately, such as the preillegalscription of anticoagulation during the treatment, drug preillegalscription and clearance for patients treated with hemodiafiltration, and hemodynamic stability. Finally, a practical guide on how to perform the treatment is provided. In this unique section, seemingly simple but important details of hemodiafiltration-treatment is discussed, such as the importance of needle size for blood flow rates, the difference between filtration fraction and substitution ratio, the different targets that can be set and how to reach them. As most literature is mainly focused on theoretical issues, this unique feature really will help the field to perform hemodiafiltration, and answer practical questions.
Chapter 1 General introduction.- PART I: TECHNICAL ASPECTS.- Chapter 2 Convective techniques.- Chapter 3 Water treatment and safety requirements.- Chapter 4 Deillegalscription of hemodiafiltration.- Chapter 5 Dialyzers for hemodiafiltration.- PART II: EFFECTS OF HEMODIAFILTRATION ON VARIOUS BIOMARKERS.- Chapter 6 Effects on electrolytes and mineral metabolism.- Chapter 7 Effects on anemia control.- Chapter 8 Effects on inflammation and oxidative stress.- Chapter 9 Effects on the removal of uremic toxins.- Chapter 10 Effects on platelets and coagulation.- PART III: CLINICAL ASPECTS OF HEMODIAFILTRATION.- Chapter 11 Clinical trials on online postdilution hemodiafiltration.- Chapter 12 Cardiovascular effects.- Chapter 13 Hemodynamic stability.- Chapter 14 Nutrition in convective treatments.- Chapter 15 Why is high volume hemodiafiltration associated with improved survival?.- Chapter 16 Hemodiafiltration in children.- Chapter 17 Intensified hemodiafiltration schemes.- Chapter 18 Potential disadvantages of hemodiafiltration.- PART IV: PRACTICAL ISSUES.- Chapter 19 Practical guide to performing high volume hemodiafiltration.- Chapter 20 Medication and hemodiafiltration.- PART V: SUMMARY AND CONCLUSIONS.- Chapter 21 Current status of hemodiafiltration.
This book provides a complete deillegalscription of online hemodiafiltration (HDF) in five sections. Sections cover topics such as technical and essential aspects of convective techniques, equipment, the effects of HDF treatment on various biomarkers, results of recent large randomized control trials and meta-analyses on HDF treatment, as well as various practical issues.
Online HDF has become an established treatment nowadays, and is supported by a vast amount of comprehensive information on a diversity of clinical and scientific aspects. This book collects and structure this information in a convenient practical guide for professionals interested in and/or working with patients with end stage kidney disease.
Hemodiafiltration - A Practical Guide is of great and global relevance for health regulatory authorities and insurance companies, dialysis industries and last but not least for the millions of patients for whom dialysis therapy is a life-saving treatment.
"It is designed to introduce hemodiafiltration to healthcare professionals and those involved in the dialysis industry, and to discuss how current dialysis therapies have not provided improved survival benefits to patients. ... It is aimed at healthcare professionals, regulating bodies, the dialysis industry, patients, and the insurance industry. ... This book is very important to modern day nephrology. ... an excellent introduction to the modality, its potential future use in treating the dialysis population, and potential for improved patient survival.” (Juan-Carlos Aycnena, Doody's Book Reviews, May, 2016)
Chapter 1 General introduction.- PART I: TECHNICAL ASPECTS.- Chapter 2 Convective techniques.- Chapter 3 Water treatment and safety requirements.- Chapter 4 Deillegalscription of hemodiafiltration.- Chapter 5 Dialyzers for hemodiafiltration.- PART II: EFFECTS OF HEMODIAFILTRATION ON VARIOUS BIOMARKERS.- Chapter 6 Effects on electrolytes and mineral metabolism.- Chapter 7 Effects on anemia control.- Chapter 8 Effects on inflammation and oxidative stress.- Chapter 9 Effects on the removal of uremic toxins.- Chapter 10 Effects on platelets and coagulation.- PART III: CLINICAL ASPECTS OF HEMODIAFILTRATION.- Chapter 11 Clinical trials on online postdilution hemodiafiltration.- Chapter 12 Cardiovascular effects.- Chapter 13 Hemodynamic stability.- Chapter 14 Nutrition in convective treatments.- Chapter 15 Why is high volume hemodiafiltration associated with improved survival?.- Chapter 16 Hemodiafiltration in children.- Chapter 17 Intensified hemodiafiltration schemes.- Chapter 18 Potential disadvantages of hemodiafiltration.- PART IV: PRACTICAL ISSUES.- Chapter 19 Practical guide to performing high volume hemodiafiltration.- Chapter 20 Medication and hemodiafiltration.- PART V: SUMMARY AND CONCLUSIONS.- Chapter 21 Current status of hemodiafiltration.
"It is designed to introduce hemodiafiltration to healthcare professionals and those involved in the dialysis industry, and to discuss how current dialysis therapies have not provided improved survival benefits to patients. ... It is aimed at healthcare professionals, regulating bodies, the dialysis industry, patients, and the insurance industry. ... This book is very important to modern day nephrology. ... an excellent introduction to the modality, its potential future use in treating the dialysis population, and potential for improved patient survival." (Juan-Carlos Aycnena, Doody's Book Reviews, May, 2016)
Menso J. Nubé is professor at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam, the Netherlands. He is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and an expert in cardiovascular disease in patients with kidney disease.
Muriel P.C. Grooteman is internist/nephrologist at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam. She is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and a specialist in cardiovascular complications of dialysis treatment.
Peter J. Blankestijn is internist/nephrologist and associate professor at the department of Nephrology at the University Medical Center Utrecht (UMCU) in Utrecht, the Netherlands. He is an expert in autonomic dysregulation in patients with end stage kidney disease, and involved in research on hemodialysis and hemodiafiltration since the 90s.
Über den Autor
Menso J. Nubé is professor at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam, the Netherlands. He is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and an expert in cardiovascular disease in patients with kidney disease.
rn
Muriel P.C. Grooteman is internist/nephrologist at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam. She is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and a specialist in cardiovascular complications of dialysis treatment.
rn
Peter J. Blankestijn is internist/nephrologist and associate professor at the department of Nephrology at the University Medical Center Utrecht (UMCU) in Utrecht, the Netherlands. He is an expert in autonomic dysregulation in patients with end stage kidney disease, and involved in research on hemodialysis and hemodiafiltration since the 90s.
rn
Inhaltsverzeichnis
Chapter 1 General introduction.- PART I: TECHNICAL ASPECTS.- Chapter 2 Convective techniques.- Chapter 3 Water treatment and safety requirements.- Chapter 4 Deillegalscription of hemodiafiltration.- Chapter 5 Dialyzers for hemodiafiltration.- PART II: EFFECTS OF HEMODIAFILTRATION ON VARIOUS BIOMARKERS.- Chapter 6 Effects on electrolytes and mineral metabolism.- Chapter 7 Effects on anemia control.- Chapter 8 Effects on inflammation and oxidative stress.- Chapter 9 Effects on the removal of uremic toxins.- Chapter 10 Effects on platelets and coagulation.- PART III: CLINICAL ASPECTS OF HEMODIAFILTRATION.- Chapter 11 Clinical trials on online postdilution hemodiafiltration.- Chapter 12 Cardiovascular effects.- Chapter 13 Hemodynamic stability.- Chapter 14 Nutrition in convective treatments.- Chapter 15 Why is high volume hemodiafiltration associated with improved survival?.- Chapter 16 Hemodiafiltration in children.- Chapter 17 Intensified hemodiafiltration schemes.- Chapter 18 Potential disadvantages of hemodiafiltration.- PART IV: PRACTICAL ISSUES.- Chapter 19 Practical guide to performing high volume hemodiafiltration.- Chapter 20 Medication and hemodiafiltration.- PART V: SUMMARY AND CONCLUSIONS.- Chapter 21 Current status of hemodiafiltration.
Klappentext
This book gives a complete deillegalscription of online hemodiafiltration, in five sections. It is unique in the systematic and complete way in which hemodiafiltration is described. Each chapter is completed by a point-to-point summary of essential information, in a separate text box. Part of the book is dedicated to the theoretical background of convective clearance. In this part, safety issues and quality control is reviewed (especially on the quality of water for dialysis and substitution fluid), as well as equipment (both dialyzers and machines) with which this treatment can be performed. As recently the results of several randomized controlled trials were available, the effect of hemodiafiltration on hard clinical end points (mortality and morbidity) is discussed in detail. This has not been done before, as the most recent book/journal on hemodiafiltration was published in 2011, before the results of the 3 randomized controlled trials were published. Furthermore, the methodological quality of the trials is discussed by an expert, in order to help the readers in their judgment of the trials Part of the book concentrates on the effect of the treatment on several biomarkers and uremic toxins. Several clinically relevant issues is discussed separately, such as the preillegalscription of anticoagulation during the treatment, drug preillegalscription and clearance for patients treated with hemodiafiltration, and hemodynamic stability. Finally, a practical guide on how to perform the treatment is provided. In this unique section, seemingly simple but important details of hemodiafiltration-treatment is discussed, such as the importance of needle size for blood flow rates, the difference between filtration fraction and substitution ratio, the different targets that can be set and how to reach them. As most literature is mainly focused on theoretical issues, this unique feature really will help the field to perform hemodiafiltration, and answer practical questions.
Gives a complete deillegalscription on online hemodiafiltration
Provides a practical guide on how to perform the treatment
Each chapter is completed by a point-to-point summary of essential information
